Overview

Wellth helps people follow their health plans by offering personalized, evidence-based programs that support long-term behavior change in behavioral health and chronic disease management. Its programs are tailored to each member and informed by behavioral economics to address the root causes of non-adherence. The products work by engaging individuals over time, using data and coaching to build sustainable healthy habits, with progress tracked to determine outcomes. What sets Wellth apart from competitors is its outcome-based payment model—clients (healthcare providers, insurers, and employers) pay only when the programs achieve validated success, aligning financial risk with real results. The overall goal is to reduce healthcare costs and improve patient outcomes by delivering measurable ROI for its clients.

Simplify's Take

What believers are saying

• $36M oversubscribed Series C in March 2025 fuels AI personalization expansion.
• Partnerships with Health New England and Gold Coast Health Plan drive 90% engagement.
• RCT-proven 51% inpatient reduction boosts Medicare star ratings and 2-4x ROI.

What critics are saying

• Omada Health erodes share with integrated AI, pulling Health New England clients.
• Teladoc undercuts with device ecosystem, achieving 2.5x ROI Wellth lacks.
• CMS 2026 rules slash Medicaid payments, forcing Gold Coast contract renegotiations.

What makes Wellth unique

• Wellth applies behavioral economics with contingency management for chronic adherence.
• AI image recognition enables seamless daily photo check-ins without extra devices.
• Real-time analytics from 50 million check-ins predict nonadherence risks early.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$73.5M

Below

Industry Average

Funded Over

7 Rounds

$36,000,000

Series C

Aug 2025

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.

Series C Funding Comparison

Below Average

Industry standards

Ind Avg. $50M

$16M

$36M

$40M

$50M

$62M

$100M

View all funding stages